← FDA DRUG APPROVALS

FDA NDA · NDA008420

RIMIFON

Sponsor: ROCHE

APPLICATION
NDA008420
TYPE
NDA
ROUTE
INJECTION, ORAL
DOSAGE FORM
INJECTABLE, SYRUP
MARKETING STATUS
Discontinued

Products

RIMIFONDiscontinued
ISONIAZID 25MG/ML · INJECTABLE · INJECTION
RIMIFONDiscontinued
ISONIAZID 100MG/ML · INJECTABLE · INJECTION
RIMIFONDiscontinued
ISONIAZID 50MG/5ML · SYRUP · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →